Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Schönlein-Henoch syndrome].

A W Lindberg1

  • 1Rigshospitalet, København, medicinsk nefrologisk afdeling P og klinisk immunologisk afdeling.

Ugeskrift for Laeger
|July 29, 1991
PubMed
Summary

Schönlein-Henoch syndrome (SHS) commonly affects children, presenting with rash, arthritis, and abdominal pain. Early diagnosis and management are crucial, especially to prevent kidney complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient factors associated with delayed diagnosis of developmental dysplasia of the hip.

Journal of children's orthopaedics·2017
Same author

[Urinary retention caused by Elsinore pills].

Ugeskrift for laeger·1988
See all related articles

Area of Science:

  • Pediatrics
  • Immunology
  • Rheumatology

Background:

  • Schönlein-Henoch syndrome (SHS) is a vasculitis primarily affecting children aged 2-8 years, with a higher incidence in boys.
  • Key symptoms include palpable purpura (skin rash), arthritis, and abdominal pain, with skin lesions appearing first in over 50% of cases.
  • The exact etiology is unknown, but it's hypothesized to involve an IgA-mediated immune response to foreign antigens.

Purpose of the Study:

  • To summarize the clinical presentation, diagnosis, and management of Schönlein-Henoch syndrome.
  • To highlight the importance of considering SHS in differential diagnoses for acute abdominal pain and arthralgia.
  • To emphasize the need for long-term monitoring for nephropathy in patients with SHS.

Main Methods:

  • Review of existing literature on Schönlein-Henoch syndrome.
  • Analysis of common clinical manifestations, diagnostic criteria, and treatment modalities.
  • Discussion of prognostic factors, particularly related to renal involvement.

Main Results:

  • SHS presents with a characteristic triad of rash, arthritis, and abdominal symptoms, though variations exist.
  • Misdiagnosis, especially of abdominal symptoms, can lead to unnecessary surgical interventions.
  • Prognosis is generally good without nephropathy, but renal involvement requires vigilant, long-term follow-up.

Conclusions:

  • Schönlein-Henoch syndrome requires a high index of suspicion, even without typical skin manifestations.
  • Current treatment strategies for SHS, particularly for preventing nephropathy, remain suboptimal.
  • Annual monitoring of blood pressure and urinalysis for protein and blood is recommended for at least five years post-SHS nephritis.

Related Experiment Videos